
The latest news from Van der Laan & Science.
-
We were awarded AtheroNETH: finding biomarkers and druggable targets for personalized primary prevention.
-
Unraveling the Heart of Type 1 Diabetes: on our U01 grant to study the immune-link between type 1 diabetes, type 2 diabetes and cardiovascular disease.
-
We were awarded this project which aims to develop a data-driven approach to AI-based phenotyping of atherosclerosis. We aim to deep-phenotype plaques and discover novel biomarkers for patient stratification.
-
Together with the Miller lab we will execute an integrative single-cell meta-analysis for atherosclerosis funded by the Chan Zuckerberg Initiative.
-
We collaborated with the Miller Lab to create PlaqView: a portal to plaque single-cell data.

PHENOMICL: detecting bleeding in atherosclerotic plaques
Together with collaborators from the University of Virginia, and Human Technopole we have developed an advanced AI system that can automatically detect and measure intraplaque haemorrhages.

dr. Joost Mekke
The ink is dry. Joost Mekke successfully presented and defended his thesis.

AtheroNETH
AtheroNETH: finding biomarkers and druggable targets for personalized primary prevention.
